The National Institutes of Health (NIH) has announced that in a new multicentre clinical trial a device known as iLet bionic pancreas was found to help type 1 diabetes patients better maintain their blood glucose (sugar) levels compared to standard insulin delivery methods.
The experimental bionic pancreas device was provided by Beta Bionics.
In the clinical trial, the device was found to be more effective at keeping blood glucose levels in the normal range.
